Company: SMNR
Filing Date: 2025-10-21
Form Type: S-1
Source: 0001193125-25-245178
Chunk: 486

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-10-21
Form: S-1
Chunk 486
---
 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).10.10^Amendment No. 2 to Master Services Agreement, dated as of June 6, 2023, by and between Semnur Pharmaceuticals, Inc. and Lifecore Biomedical, LLC. (incorporated by reference to Exhibit 10.21 of Amendment No. 7 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).10.11Assignment Agreement by and among Shah Investor LP and the Company, dated as of August 6, 2013. (incorporated by reference to Exhibit 10.22 of Amendment No. 7 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).10.12Advisory Services Agreement, dated as of August 26, 2024, by and between Wise Orient Investments Limited and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.23 of Amendment No. 7 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).II-5
| Exhibit 
 Number  
 10.12.1 
 10.13   |     | Description                                                                                                                                                                                                                                                                                                                             
 Amendment to Advisory Services Agreement, dated as of July 22, 2025, by and between Wise Orient Investments Limited and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.23.1 of Amendment No. 7 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).                            
 Advisory Services Agreement, dated as of August 25, 2024, by and between 450W42ND MIMA, LLC and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit 10.24 of Amendment No. 7 to Denali’s registration statement on Form S-4 filed with the SEC on August 12, 2025).                                                      |
|:--------|:----|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 10.13.1 |     | Amendment to Advisory Services Agreement, dated as of July 22, 2025, by and between 450W42ND MIMA, LLC and Semnur Pharmaceuticals, Inc. (incorporated by reference to Exhibit